公开(公告)号：CA2233204A1

公开(公告)日：1997-04-03

申请号：CA2233204

申请日：1996-09-27

Applicant: COR THERAPEUTICS INC ,  LILLY CO ELI

Inventor： PAAL MICHAEL ,  RUEHTER GERD ,  SCHOTTEN THEO ,  MULLANEY JEFFREY T ,  RUTHERBORIES KENNETH J ,  MASTERS JOHN J ,  SCARBOROUGH ROBERT M ,  FISHER MATTHEW J ,  JAKUBOWSKI JOSEPH A ,  STENZEL WOLFGANG

IPC: A61K31/00 ,  A61K31/42 ,  A61K31/423 ,  A61K31/435 ,  A61K31/437 ,  A61K31/438 ,  A61K31/535 ,  A61K31/537 ,  A61K31/5375 ,  A61K31/5377 ,  A61K31/5383 ,  A61P7/00 ,  A61P7/02 ,  C07D221/20 ,  C07D263/52 ,  C07D471/10 ,  C07D498/10 ,  C07D519/00 ,  C07D401/06 ,  C07D487/10 ,  C07D513/10 ,  C07D491/107 ,  C07D265/12 ,  C07D223/14 ,  A61K31/395 ,  A61K31/675

Abstract: This invention relates to certain spirocyclic compounds substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.